AstraZeneca Stock Rises as US, Cancer Drug Growth Lifts Q2 Results

  • AstraZeneca (AZN) shares are rising in premarket trading Tuesday after the pharma giant beat second-quarter estimates on strong U.S. growth and demand for its cancer drugs.